This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Abnova
product type :
antibody
product name :
TYMP monoclonal antibody, clone P-GF.44C
catalog :
MAB14507
quantity :
100 ug
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
P-GF.44C
The same clone is also sold as:
The same clone is also sold as:
- Invitrogen: MA5-13542, MA1-46059
- OriGene: DM292, DM292-05
- Abcam: ab218381
- Santa Cruz Biotechnology: sc-47702 HRP, sc-47702 AC, sc-47702
reactivity :
human
application :
western blot, immunoprecipitation, immunohistochemistry - paraffin section
product information
catalog id :
MAB14507
product name :
TYMP monoclonal antibody, clone P-GF.44C
product description :
Mouse monoclonal antibody raised against full length recombinant human TYMP.
clone name :
P-GF.44C
isotype :
IgG1
gene name :
TYMP
gene alias :
ECGF1 MNGIE PDECGF TP hPD-ECGF
gene description :
thymidine phosphorylase
immunogen :
Recombinant protein corresponding to full length human TYMP.
protein accession :
P19971
form :
Liquid
recommend dilutions :
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (1-2 ug/mL). Immunoprecipitation (0.5-1 ug/500 ug protein lysate). Western Blotting (0.5-1 ug/mL). The optimal working dilution should be determined by the end user.
storage buffer :
In 10 mM PBS (0.05% BSA, 0.05% sodium azide).
storage instruction :
Store at 4 C.
note :
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
type clonality :
Antibody
raised in host species :
Mouse
antigen species target species :
Human
species reactivity cross reactivity :
Human
application key :
WB,IP,IHC-P
size :
100 ug
autodate :
2016-12-30
updatetime :
2016-12-30 10:15:00
company information
Abnova
9th Fl., No.108, Jhouzih St.
Neihu District. Taipei City
114 Taiwan
Neihu District. Taipei City
114 Taiwan
sales@abnova.com
https://www.abnova.com877-853-6098
questions and comments